12:00 AM
 | 
May 02, 2013
 |  BC Innovations  |  Distillery Techniques

Technology: Drug platforms

This week in techniques
Approach Summary Licensing status Publication and contact information
Drug platforms
Fibroblast-derived induced oligodendrocyte progenitor cells (iOPCs) to treat myelination disorders Two separate studies developed methods to reprogram mouse fibroblasts into iOPCs and suggested they could be used to help treat...

Read the full 294 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Innovations

Article Purchase

$35 USD
More Info >